SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-20-000059
Filing Date
2020-05-11
Accepted
2020-05-11 16:01:01
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q blph03312010q.htm 10-Q 664089
2 EXHIBIT 31.1 blph03312010qexhibit311.htm EX-31.1 9918
3 EXHIBIT 31.2 blph03312010qexhibit312.htm EX-31.2 9907
4 EXHIBIT 32 blph03312010qexhibit32.htm EX-32 10904
  Complete submission text file 0001600132-20-000059.txt   3730448

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blph-20200331.xml EX-101.INS 682082
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20200331.xsd EX-101.SCH 33001
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20200331_cal.xml EX-101.CAL 40168
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20200331_def.xml EX-101.DEF 153249
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20200331_lab.xml EX-101.LAB 448024
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20200331_pre.xml EX-101.PRE 257544
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 20864639
SIC: 2834 Pharmaceutical Preparations